Kevin Richard Haas Insider Profile
11 Followers
Kevin Richard Haas, CTO at Myriad Genetics, holds 44.22K shares in Veracyte (Ticker: VCYT), holds 180.02K shares in Myriad Genetics (Ticker: MYGN).
Kevin Richard Haas has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin Richard Haas holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kevin Richard Haas
Kevin Richard Haas's Trading History
Myriad Genetics
Mar 16, 2026
CTO
Uninformative Sell
103.96K
$864.11K
Veracyte
Apr 14, 2026
Chief Dev and Tech Officer
Uninformative Buy
―
$1.46M
List of latest transactions for each holding click on a transaction to see Kevin Richard Haas's performance on stock
You May Also Like
Kevin Richard Haas insider profile FAQ
What is the percentage of profitable transactions made by Kevin Richard Haas?
The percentage of profitable transactions made by Kevin Richard Haas is ―.
What is the average return per transaction made by Kevin Richard Haas?
The average return per transaction made by Kevin Richard Haas is ―.
What stocks does Kevin Richard Haas hold?
Kevin Richard Haas holds: MYGN, VCYT stocks.
What was Kevin Richard Haas’s latest transaction?
Kevin Richard Haas latest transaction was an Uninformative Buy of ―.
What was Kevin Richard Haas's most profitable transaction?
Kevin Richard Haas’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kevin Richard Haas's role in Myriad Genetics?
Kevin Richard Haas's role in Myriad Genetics is CTO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.